Business

AGM Statement and Integration Update

AGM Statement and Integration Update.

articleCraneware PlcNovember 16, 20213/company/craneware-plc/news/agm-statement-and-integration-update
AGM Statement and Integration Update

About this update from Craneware Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 4465S\n Craneware plc\n 16 November 2021\n  \n \n \n \n 16 November 2021 \n \n \n  \n \n \n Craneware plc\n \n \n (\"Craneware\" or the \"Company\")\n \n \n  \n \n \n AGM Statement and Integration Update\n \n \n  \n \n \n Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting for the financial year ended 30 June 2021 which takes place at 10am today. \n \n \n  \n \n \n The Company has continued to make positive progress during the first four months of the new financial year, trading in line with management's expectations. \n \n \n \n \n Integration progressing well\n \n \n \n  \n \n \n The integration of Sentry Data Systems is progressing ahead of plan, with the integration of operational departments and operating systems nearing completion and the sales and technology teams on track to be fully integrated by the end of the current financial year. Good levels of initial synergies have already been realised, more than fully mitigating the salary inflation currently being seen across the industry. Morale in the enlarged group is strong with a collective passion to \"transform the business of healthcare\" resulting in a lower attrition rate than the industry average widely reported.   \n \n \n  \n \n \n Positive sales activity\n \n \n  \n \n \n Sales activity is high, with initial cross-sale opportunities emerging, as anticipated, across the two customer sets alongside new customer opportunities. The migration of existing customers to the Trisus platform continues to plan with all customers expected to be migrated by the end of calendar year 2022. \n \n \n  \n \n \n Increased scale and opportunity\n \n \n  \n \n \n The acquisition of Sentry has significantly increased Craneware's scale and opportunity, expanding the Group's pharmacy offerings, customer base and valuable data sets, as well as increasing total revenue visibility for the next three years to approximately half a billion dollars. \n \n \n  \n \n \n Craneware's AI and data science team continue to analyse what the Company believes to be the largest and most relevant independent proprietary hospital data set in the world. The Group's aim is to identify futu...

More updates from Craneware Plc